INNOVATIVE INDUSTRIAL PROPERTIES INC Q4 FY2024 earnings call

• The company generated over $255 million in cash flow from operations and returned over $210 million to shareholders via dividends.
• Deployed over $70 million in capital to acquire two properties and executed new leases at six properties (530,000 sq ft, 6% of portfolio).
• Upsized credit facility to $87.5 million with four banks participating.
• Announced retirement of two independent directors, David Stecker and Mary Curran.
• Promoted Tracy Hager and Kelly Spiker to Senior Vice President.
• Resolved PharmaCann default with PharmaCann recommencing rent payments on nine of eleven leases, a capital infusion, and a junior secured note.
• Discussed regulatory developments including potential federal cannabis reform, rescheduling challenges with DEA, and state market developments like Pennsylvania and Florida cannabis initiatives.
• In 2024, deployed $70 million across five properties, had one asset under contract for $7.8 million, and finished 2024 with operating portfolio over 98% leased.

For the year ended 2024, the company generated total revenues of $308.5 million. Cash flow from operations was over $255 million, and over $210 million was returned to shareholders through dividends. They deployed over $70 million in capital to acquire two properties and executed new leases at six properties representing 530,000 square feet (6% of total portfolio). AFFO for the year was $256.1 million. The balance sheet remained strong with a debt to gross assets ratio of 11% and total available liquidity exceeding $235 million.

• Total available liquidity exceeded $235 million, providing ample dry powder for additional strategic investments.
• Anticipate continued focus on selective investment opportunities in the cannabis industry.
• Expect industry growth with projected 10% sales increase in 2025 after 9.8% growth in 2024.

• Illicit and gray markets undermining the regulated cannabis industry.
• Regulatory challenges, including stalled DEA rescheduling efforts.
• Tenant debt maturities in 2026 posing potential stress for tenants.

Q: Regarding tenant risks, especially with 2026 debt maturities, how is the company thinking about tenant base risk?

A: Alan Gold noted the industry has green shoots and believes the broader market should be better positioned to handle 2026 maturities, but they are closely monitoring tenant debt issues.

Q: Could the company play a role in helping tenants with debt issues via sale-leasebacks?

A: Alan Gold said the company has a strong balance sheet and liquidity to consider opportunities but believes the broader industry needs to perform better first.

Q: What are the next checkpoints for rescheduling hearings postponed by DEA?

A: Paul Smithers stated the industry is waiting to see White House direction, as appointments like Terrence Cole at DEA and Pam Bondi as AG await clarity on rescheduling, with potential guidance from President Trump needed to restart the process.

Q: Color on security deposits applied, especially from PharmaCann?

A: Alan Gold and Ben Regin mentioned working closely with tenants on individual situations, focusing on tenant health and industry green shoots.

Q: Clarification on strategic investments and whether they include non-cannabis?

A: Ben Regin said they are primarily focused on the cannabis industry but have a broadened view to enhance revenue through real estate-related income.

Q: Elaboration on green shoots in cannabis industry and competition?

A: Paul Smithers cited projections of 10% growth in 2025, state initiatives like Tennessee introducing bills, Illinois breaking records, and consolidation in larger states as green shoots, with competition leading to grower dropout and consolidation.

Q: Handling discussions with tenants about rent reductions post-PharmaCann resolution?

A: Alan Gold stated it's difficult to comment specifically as it's confidential, but the company focuses on tenants living up to lease agreements.

Q: Mix of cultivation vs retail assets and multistate vs single state tenants?

A: Alan Gold said the company is highly focused on cultivation assets and underwriting criteria targets best operators, whether multistate or single state.

Q: When will investment in cannabis industry commensurate with growth resume?

A: Alan Gold cited illicit market reduction and safer banking provisions as key factors needed for renewed investment, expecting these to come but not immediately.

Q: Reassessment of tenant credit, especially MSOs like PharmaCann?

A: Alan Gold said the company is monitoring all tenants, including strongest ones, and doing deep dives into their creditworthiness.